Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05837611
Other study ID # 22-22
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 10, 2022
Est. completion date July 1, 2024

Study information

Verified date May 2023
Source University of North Texas, Denton, TX
Contact Jamie R Pogue
Phone 9403698308
Email Jamie.pogue@unt.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will examine the effects of an incentive-based intervention (for reducing alcohol use) that would be sustainable, easily accessible intervention using remote alcohol monitoring and deposit contracts, targeting individuals who would not be reached by more traditional forms of treatment due to barriers such as time constraints, attitudes, and stigma.


Description:

Deposit contracts are effective at treating a wide variety of problems: smoking cessation, weight loss, and increasing physical activity. Despite the promise of deposit contracts, few earlier studies targeted problem drinking, since doing so required burdensome frequent monitoring - now overcome by remote alcohol monitoring. Earlier work relied on self- and collateral reports, breath alcohol concentrations during clinic visits, or an indirect non-specific marker of alcohol use. Despite these difficulties, earlier studies of deposit contracts were encouraging, with notable increases in: therapy participation; retention ; and abstinence duration compared to previous reports. Collectively, these studies show the potential of deposit contracts to reduce problem drinking but provide only limited evidence of its effectiveness. Still, these studies, and our recent success using contingency management with remote alcohol monitoring, provide a compelling rationale for examining whether a deposit contract program might provide a feasible, effective, and accessible way of helping people reduce drinking. Though there is limited systematic research on deposit contracts, deposit contract programs for various problems are widely available and have proven quite attractive. For example, a deposit contract weight loss website, has over 887,000 users with $62M in incentives paid. However, it is unclear if deposit contracts would be acceptable (and therefore feasible) to individuals interested in reducing their problem drinking. Therefore, we feel that the proposed deposit contract intervention utilizing remote alcohol monitoring could be a widely available and acceptable intervention for problem drinking for three reasons: (1) because of the effectiveness and convenience of our contingency management intervention using remote alcohol monitoring; (2) because of the widespread success of other deposit contract programs like DietBetã; and (3) because the potentially increased attractiveness and effectiveness of an intervention that can return an amount greater than the deposit. The adoption of a deposit contract intervention plus remote alcohol monitoring will only be accelerated by the "FitBit"-style alcohol monitoring devices being developed by many companies (we are currently independently evaluating one such device). However, making deposit contracts widely available will need evidence of their effectiveness, which requires large randomized controlled trials. The purpose of this R21 application is to develop this evidence by demonstrating that deposit contracts with remote alcohol monitoring are feasible and provide evidence of effectiveness needed to design and justify future studies.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date July 1, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - at least 21 years of age - report > 8 heavy drinking episodes during the last 28 days - want to reduce their alcohol use - are willing to wear a transdermal alcohol monitor - own a smartphone - are willing and able to deposit $200

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Deposit Contract
A deposit contract requires individuals to put down money that is earned back contingently upon meeting their goals.
Other:
Transdermal Alcohol Monitoring
Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Locations

Country Name City State
United States University Of North Texas Denton Texas

Sponsors (2)

Lead Sponsor Collaborator
University of North Texas, Denton, TX The University of Texas Health Science Center at San Antonio

Country where clinical trial is conducted

United States, 

References & Publications (9)

Bigelow G, Strickler D, Liebson I, Griffiths R. Maintaining disulfiram ingestion among outpatient alcoholics: a security-deposit contingency contracting procedure. Behav Res Ther. 1976;14(5):378-81. doi: 10.1016/0005-7967(76)90028-0. No abstract available. — View Citation

Burns RJ, Rothman AJ. Comparing Types of Financial Incentives to Promote Walking: An Experimental Test. Appl Psychol Health Well Being. 2018 Jul;10(2):193-214. doi: 10.1111/aphw.12126. Epub 2018 Apr 19. — View Citation

Dallery J, Raiff BR, Grabinski MJ, Marsch LA. Technology-Based Contingency Management in the Treatment of Substance-Use Disorders. Perspect Behav Sci. 2019 Jul 9;42(3):445-464. doi: 10.1007/s40614-019-00214-1. eCollection 2019 Sep. — View Citation

Ersner-Hershfield SM, Connors GJ, Maisto SA. Clinical and experimental utility of refundable deposits. Behav Res Ther. 1981;19(5):455-7. doi: 10.1016/0005-7967(81)90137-6. No abstract available. — View Citation

Jarvis BP, Dallery J. Internet-based self-tailored deposit contracts to promote smoking reduction and abstinence. J Appl Behav Anal. 2017 Apr;50(2):189-205. doi: 10.1002/jaba.377. Epub 2017 Feb 17. — View Citation

Paxton R. The effects of a deposit contract as a component in a behavioural programme for stopping smoking. Behav Res Ther. 1980;18(1):45-50. doi: 10.1016/0005-7967(80)90068-6. No abstract available. — View Citation

Pomerleau O, Pertschuk M, Adkins D, Brady JP. A comparison of behavioral and traditional treatment for middle-income problem drinkers. J Behav Med. 1978 Jun;1(2):187-200. doi: 10.1007/BF00846639. — View Citation

Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008 Dec 10;300(22):2631-7. doi: 10.1001/jama.2008.804. — View Citation

White JS, Dow WH, Rungruanghiranya S. Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand. Am J Prev Med. 2013 Nov;45(5):533-42. doi: 10.1016/j.amepre.2013.06.020. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Transdermal Alcohol Content Measurement produced while wearing Transdermal Alcohol Monitor 4 weeks continuously
See also
  Status Clinical Trial Phase
Completed NCT03165942 - Neuroendocrine Response to Oral Alcohol Administration Phase 1
Recruiting NCT05343039 - Technology Enhanced Adolescent Mental Health (TEAM) N/A
Active, not recruiting NCT04070521 - EEG Monitoring in the Emergency Department
Completed NCT03169244 - Buproprion for Binge Drinking Phase 2
Recruiting NCT05246202 - Personalized Feedback Intervention for Latinx Drinkers With Anxiety N/A
Completed NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A
Recruiting NCT04368416 - Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Not yet recruiting NCT04557631 - Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
Terminated NCT00890149 - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Phase 2
Completed NCT02681406 - Smartphone Based Continuing Care for Alcohol N/A
Completed NCT02448134 - A Community-Based Strategy for Preventing Underage Drinking N/A
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Withdrawn NCT01796158 - Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use N/A
Withdrawn NCT01847300 - cSBI-M for Young Military Personnel N/A
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Withdrawn NCT01511679 - Brain-imaging and Adolescent Neuroscience Consortium N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Withdrawn NCT01275391 - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use Phase 1/Phase 2
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT00907309 - Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use Phase 1/Phase 2